Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT
Jordi Esteve*, Sebastian Giebel*, Myriam Labopin, Tomasz Czerw, Depei Wu, Liisa Volin, Gerard Socié, Ibrahim Yakoub-Agha, Johan Maertens, Jan J. Cornelissen, Arnaud Pigneux, Avichai Shimoni, Rainer Schwerdtfeger, Hélène Labussière-Wallet, Nigel Russell, Anton Schattenberg, Patrice Chevallier, Vladimir Koza, Robin Foà, Christoph SchmidZinaida Peric, Mohamad Mohty, Arnon Nagler
Research output: Contribution to journal › Article › peer-review
12Scopus
citations
Fingerprint
Dive into the research topics of 'Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT'. Together they form a unique fingerprint.